Compare Mirae Asset Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹99
₹100
Expense Ratio
1.94
1.87
NAV
₹44.03
₹41.93
Fund Started
11 Jun 2018
25 Jun 2018
Fund Size
₹2753.72 Cr
₹6293.14 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year
7.59%
5.59%
3 Year
23.13%
26.04%
5 Year
13.94%
15.55%
Equity
99.92%
97.62%
Cash
0.08%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.20% |
Divi's Laboratories Ltd. | 7.93% |
Glenmark Pharmaceuticals Ltd. | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. | 6.88% |
Apollo Hospitals Enterprise Ltd. | 6.15% |
Lupin Ltd. | 5.06% |
Aurobindo Pharma Ltd. | 4.32% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Fortis Healthcare Ltd. | 3.73% |
Laurus Labs Ltd. | 3.56% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
11 Jun 2018
25 Jun 2018
